Source: Channel News Asia.

Law & Home Affairs Minister K Shanmugam says that pharmaceutical companies are hiding their intentions behind a smokescreen when it comes to cannabis. He describes the trend of accepting cannabis medical use is driven by the “power of money and propoganda”.

Mr Shanmugam said this just before a joint statement by the Home Affairs and Health ministries which set out the government’s position the use of pharmaceutical products containing cannabinoids.

The ministries clearly differentiated between pharmaceutical products with potential therapeutic uses, and products containing unprocessed or raw cannabis which they affirm have addictive and harmful properties.

They said, “To date, there are no studies which have validated the claims of unprocessed or raw cannabis being able to treat medical conditions,”

In December, Thailand became the first country in Southeast Asia to legalise the use of cannabis for medical purposes. Malaysia and the Philippines have considered following suit.

Mr Shanmugam voiced his thoughts that pharmaceutical companies are pushing a different line for financial gain, Mr Shanmugam told the programme Insight, in an episode on the implications of Thailand’s legalisation of what some term medical cannabis.

He said, “The research, in our view, is quite clear. The Institute of Mental Health (IMH) did a review of 500 articles between 1964 and 2015 on the effects of cannabis. It causes serious brain damage. One in two get addicted.”

“The companies, which are interested in making money out of this – really dealing in destruction and death – have found a new way of arguing it.”

The studies reviewed by IMH were published in medical journals and other literature by international medical bodies. The IMH concluded that “cannabis consumption is associated with irreversible brain damage, brain shrinkage and serious mental/psychiatric illnesses.

On the other hand, they found that are some medicine with cannabinoid products that are scientifically researched and medically approved. These can be administered through pharmaceutical products such as oral solutions and sprays.

There is even published research, derived from clinical trials, on the potential uses of cannabinoids to manage seizures and epilepsy, cited the ministries.

However, they iterated that such cannabinoid pharmaceuticals will have to be reviewed by the Health Sciences Authority (HSA) before they can be registered for supply in Singapore.

“Manufacturers are required to substantiate the safety, quality and efficacy of the cannabinoid pharmaceuticals based on scientific evidence from clinical studies and data on the manufacturing process,” read the joint statement.

Mr Shanmugam continued by saying that company have taken that concept – the potential medical use of cannabinoids – and labelled it as ‘cannabis is good for you for medicinal purposes’, while spending a lot of money advertising it.

“Some governments, quite frankly, then also look at the potential tax revenues. Though that’s a bum game, because I think in the states that have legalised, they find that the cost associated with increased health-related problems far outstrip any tax revenues,” he added.

The minister dismissed the case for legalising it as “full of holes” and illogical. He also described the term “medical cannabis” as a way to “whitewash the whole subject”.

“If you want medical cannabis, what you’re really saying is certain cannabinoid compounds, which are already included in some medicines, which can be prescribed… So why do you need to go from there to consuming raw, unprocessed cannabis?” he questioned.

“For a medicinal purpose, if a doctor certifies the need for a certain type of medicine that has a cannabinoid compound, there’s no problem.”

Currently, there are strict frameworks in place for the supply, prescription, and dispensing of controlled drugs for medical purposes. These drugs can have to be prescribed by a Singapore doctor for the medical condition registered with the HSA.

The ministries asserted that the policies are underpinned by research. As such, the lack of scientific evidence of the safety and efficacy of raw cannabis use supports their position that cannabis should remain an illicit drug.

Asked if a clearer distinction between support for medical and illegal drug use is needed, he replied that people would understand if it were explained, instead of being perverted to serve propaganda.

“The pharmaceutical companies can’t go out there and say: We want you to buy more drugs, and we want to make more money out of you,” he added.

“So they try and persuade you that they’re doing this to your benefit because it’s ‘medicinal’, you see. It‘s bunkum.”

The public have called out Mr Shanmugam on his comments that pharmaceutical companies are pushing a different line for financial gain when it comes to cannabis, asking why tobacco and alcohol are still widely available in Singapore when both are highly addictive and harmful substances as well:

Some even pointed out that cannabis has been proven to be effective, especially for people suffering from chronic or terminal illnesses:

While one netizen asked why there’s such a fuss over cannabis for medical purposes when other stronger drugs are already being used in the hospital setting:

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments
You May Also Like

Vote fearlessly to end the PAP’s supermajority, urged PSP’s Lee Hsien Yang

People should vote “fearlessly” urged, Lee Hsien Yang of the Progress Singapore…

“欢迎回来协助调查” 卫生部、警方和监狱署联合反驳费雷拉指控

针对美国男子费雷拉在今早脸书反驳未曾盗窃和泄露艾滋病患机密资料,并对我国卫生部等机构作出指控,卫生部、警方和监狱署发表声明反驳,并欢迎费雷拉回来新加坡协助调查。 费雷拉爆料,指泄露资料者乃是另一名为Zachary Levine的洋汉,对此警方在声明中表示,在2016年已经根据费雷拉的举报,对Levine展开调查,甚至骇搜查了后者的住所,但没有证据显示他拥有卫生部相关文件,或曾分享艾滋资料库的数据。 至于费雷拉指他在扣留期间被虐待,警方称经查已证实子虚乌有。 “已调查证实被性侵一事不实” 而费雷拉自称在狱中被性侵才感染艾滋,但警方和监狱署回应,对于费雷拉举报被性侵一事,当时交由犯罪调查部门调查,惟最后证实不实。 同时当局也透露,在监禁期间费雷拉涉多次违例,包括袭击其他囚犯。而他早在2016年6月入狱前,就承认他自2008年就已是艾滋阳性带原者。 未干预费雷拉在狱中接受艾滋治疗 此外,费雷拉指有检察官干预他在狱中接受治疗,对此监狱署表示自2016年6月入狱,费雷拉拒绝验血,最终透过在卫生部协助下才得以给他必要的治疗,总监察署不曾干预其治疗。 卫生部则在文告中指出,卫生部长颜金勇昨天已在国会发表部长声明,详述了整个事件的事发经过。 卫生部指费雷拉继续做出虚假、无根据的指控。对于后者恐吓将公布更多资料,卫生部表示将和警方联手“采取适当的行动”。 卫生部也否认费雷拉所指,有关艾滋数据库乃是特别针对男同性恋,而是用于记录艾滋病感染率的统计数据,也会每年对外发布。…

台湾宜兰县南方澳跨港大桥坍塌 渔船遭压 抢救伤员

台湾宜兰县南方澳跨港大桥今天上午发生坍塌意外,现场压到3艘渔船,消防局第一时间即派员前往救援,并派遣直升机进行空勘记协助救援,截至下午2点左右救出10名伤者送医,仍有5人失联。 据台湾各地报道指出,事发时一辆油罐车正从桥上驶过,不料就在即将驶出桥之际突然发生断裂,油罐车也跟著下坠掉入码头,当场起火燃烧,窜起阵阵浓烟,驾驶稍早已经脱困获救,惟其伤势相当严重。 警方在接获通报后,全员出动进行救援,至于灾损多少,仍待厘清。 大桥坍塌后,压毁两艘渔船冒出浓烟,初估现场有20多人受伤,目前已救起10人,重伤六人,轻伤四人,持续抢救中。 除了油罐车司机是台湾籍人士以外,其他均为外籍渔工。 罗东博爱医院外科加护病房主任杨智杰表示,司机目前痛到说不出话来,但只记得事发时发生很大震动,听到“碰”的一声,便跌落桥下。而另5名失踪人士则为外籍船员,消防局出动潜水人员寻找生还者,但仍未寻获,目前正启动大型吊车,将被压垮的渔船吊起,以利进一步搜救。 南方澳跨港大桥于1999年兴建跨港大桥,大桥离海平面18公尺,以解决大型渔船无法通行之困境,使得南方澳渔港得以长远发展。 但据《联合新闻网》指出,近年负责维修的工程顾问公司曾在维修过程中发现缆绳已严重锈蚀,以及桥上多个链接处都曾遭车辆撞击,桥梁安全有问题,因此多次向港务公司提出,但却一直没有下文。 也有附近居民怀疑是因为去年海堤修复,载送大量消波块,因此压坏大桥,对此,基隆港务分公司主任林建明表示,消波快重量应在容许范围内。而港务公司总经理陈邵良说明,该桥平常也在进行维修,供游客、商业、渔业共用,至于断裂原因正在了解中,已请相关人员到现场了解。

Returning travellers reminded to pay GST for goods exceeding $600

Going for an overseas trip soon? Please be reminded that all goods brought…